此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparison of Routine Versus Restrictive Episiotomy in Primigravida Women at Term.

2026年8月27日 更新者:Muhammad Aamir Latif

Comparison of Outcome in Terms of Perineal Tear and Postpartum Hemorrhage (PPH) in Routine Versus Restrictive Episiotomy in Primigravida Women at Term.

The ongoing debate over routine versus selective episiotomy in primiparous term women underscores the necessity for updated local data. Consequently, this study was designed to compare the outcomes-specifically regarding perineal tears and postpartum hemorrhage (PPH)-between routine and selective episiotomy in primigravida women at term.

研究概览

详细说明

Perineal tears remain a common concern following normal vaginal delivery, particularly among primigravida women delivering at term. Episiotomy has traditionally been performed to reduce the risk or severity of perineal trauma, although the benefits of routine versus selective episiotomy remain a subject of ongoing debate. While routine episiotomy may be considered protective in some circumstances, restrictive use has also been advocated to avoid unnecessary perineal injury and other associated complications. This study aims to provide baseline data on perineal tears among primigravida women undergoing normal vaginal delivery, thereby promoting greater vigilance during labor and delivery. The findings may also help obstetricians make informed decisions regarding the appropriate use and justification of episiotomy in this population.

研究类型

介入性

注册 (实际的)

466

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Punjab Province
      • Multan、Punjab Province、巴基斯坦、66000
        • Nishtar Hospital/Medical University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人

接受健康志愿者

不

描述

Inclusion Criteria:

  • Primigravida
  • Aged18 - 40 years
  • Gestational age of ≥ 37 weeks
  • Admitted to the labor room (either spontaneous or induced labor) for episiotomy

Exclusion Criteria:

  • Abnormal and cephalic presentations with occipitoposterior position
  • Instrumental delivery (vacuum or forceps)
  • Pre - eclampsia / Eclampsia
  • Gestational diabetes mellitus
  • Fetal abnormality
  • Intrauterine growth restriction
  • History of pelvic surgery or neuromuscular diseases
  • Twin pregnancies
  • Fetal macrosomia

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Routine Episiotomy
Patients were managed by routine method in which episiotomy was performed without any indication.
Patients were managed by routine method in which episiotomy was performed without any indication.
实验性的:Restrictive Episiotomy
The patient underwent restrictive episiotomy when clinically indicated due to a risk of a third- or fourth-degree perineal tear or fetal compromise.
The patient underwent restrictive episiotomy when clinically indicated due to a risk of a third- or fourth-degree perineal tear or fetal compromise.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Perineal tear
大体时间:Immediately after the procedure
Frequency of patients with perineal tear, defined as presence of laceration or disruption at any level from skin to the muscles and anal sphincters, was noted, .
Immediately after the procedure
Postpartum Hemorrhage
大体时间:Immediately after the procedure
Frequency of patients with postpartum hemorrhage, defined as Blood loss of more than 500 mL after vaginal delivery measured as one full kidney tray, was noted.
Immediately after the procedure

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Ammara Khaliq、Nishtar Hospital/Medical University, Multan, Pakistan.
  • 研究主任:Syeda Ali, FCPS、Nishtar Hospital/Medical University, Multan, Pakistan.

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年5月1日

初级完成 (实际的)

2025年10月31日

研究完成 (实际的)

2025年10月31日

研究注册日期

首次提交

2026年8月27日

首先提交符合 QC 标准的

2026年8月27日

首次发布 (实际的)

2026年9月1日

研究记录更新

最后更新发布 (实际的)

2026年9月1日

上次提交的符合 QC 标准的更新

2026年8月27日

最后验证

2026年8月1日

更多信息

与本研究相关的术语

其他研究编号

  • Dr-Ammara-Multan

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Data can be shared on a reasonable request.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅